Stay updated with breaking news from Tumor Treating. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Durable survival effect observed in the largest prospective, non-interventional study completed examining TTFields therapy use in newly diagnosed GBM Topline data to be presented Saturday, June 1,...
NVCR earnings call for the period ending March 31, 2024.
Quarterly net revenues of $139 million, up 13% year-over-year, with 3,845 active patients on therapy as of March 31, 2024 Phase 3 METIS trial in brain metastases from non-small cell lung cancer met...
Novocure today announced 20 presentations on Tumor Treating Fields therapy will be delivered at the American Association for Cancer Research Annual Meeting 2024, to be held April 5 to 10 in San...
OurBrainBank is putting a spotlight on the devastating inequities that exist for those with GBM to spark debate and force more to be done for those who need it.